Kyowa Hakko Kirin
|
2,180.50 |
|
-22.50 |
-1.02% |
-17.00% |
2025-04-17 |
Astellas Pharma
|
1,320.50 |
|
-2.00 |
-0.15% |
-10.11% |
2025-04-17 |
AbbVie
|
171.57 |
|
-5.40 |
-3.05% |
4.37% |
2025-04-16 |
Agios Pharmaceuticals
|
27.15 |
|
-0.67 |
-2.41% |
-6.48% |
2025-04-16 |
Alnylam Pharmaceuticals
|
230.50 |
|
-0.43 |
-0.19% |
58.62% |
2025-04-16 |
Amgen
|
282.84 |
|
-12.60 |
-4.26% |
7.04% |
2025-04-16 |
AstraZeneca
|
10,254.00 |
|
-26.00 |
-0.25% |
-5.60% |
2025-04-16 |
Biogen
|
115.16 |
|
-1.81 |
-1.55% |
-40.98% |
2025-04-16 |
BioMarin Pharmaceutical
|
58.83 |
|
-1.19 |
-1.98% |
-34.97% |
2025-04-16 |
Bristol-Myers Squibb
|
49.33 |
|
-0.64 |
-1.28% |
3.03% |
2025-04-16 |
Gilead Sciences
|
104.93 |
|
-0.72 |
-0.68% |
56.61% |
2025-04-16 |
GlaxoSmithKline
|
1,345.50 |
|
-0.50 |
-0.04% |
-15.38% |
2025-04-16 |
Incyte
|
57.73 |
|
-0.73 |
-1.25% |
9.36% |
2025-04-16 |
Ionis Pharmaceuticals
|
28.35 |
|
-0.03 |
-0.11% |
-30.70% |
2025-04-16 |
J&J
|
153.97 |
|
0.34 |
0.22% |
6.38% |
2025-04-16 |
Eli Lilly
|
735.00 |
|
-21.61 |
-2.86% |
-2.15% |
2025-04-16 |
Merck
|
76.39 |
|
-1.84 |
-2.35% |
-39.16% |
2025-04-16 |
Moderna
|
25.19 |
|
-1.04 |
-3.95% |
-75.66% |
2025-04-16 |
Neurocrine Biosciences
|
100.10 |
|
3.94 |
4.10% |
-24.87% |
2025-04-16 |
Novartis
|
90.46 |
|
0.26 |
0.29% |
6.61% |
2025-04-16 |
Novartis
|
109.57 |
|
-0.25 |
-0.23% |
17.83% |
2025-04-16 |
Pfizer
|
22.05 |
|
-0.40 |
-1.78% |
-13.36% |
2025-04-16 |
Ultragenyx Pharmaceutical
|
34.98 |
|
-0.36 |
-1.02% |
-20.70% |
2025-04-16 |
Regeneron Pharmaceuticals
|
549.97 |
|
-7.97 |
-1.43% |
-39.00% |
2025-04-16 |
Roche Holding
|
254.40 |
|
-1.00 |
-0.39% |
15.58% |
2025-04-16 |
Sanofi
|
50.57 |
|
-0.03 |
-0.05% |
10.34% |
2025-04-16 |
Sarepta Therapeutics
|
53.94 |
|
-0.48 |
-0.88% |
-54.25% |
2025-04-16 |
Teva Pharmaceutical Industries
|
5,059.00 |
|
36.00 |
0.72% |
2.20% |
2025-04-16 |
United Therapeutics
|
285.19 |
|
0.37 |
0.13% |
21.20% |
2025-04-16 |
Vertex Pharmaceuticals
|
486.21 |
|
-14.14 |
-2.83% |
23.55% |
2025-04-16 |